comparemela.com

Latest Breaking News On - Tang capital management - Page 1 : comparemela.com

TR-1: Notification of major holdings | Company Announcement

Investegate announcements from TR-1: Notification of major holdings

United statesSan diegoUnited kingdomCity ofKevin tangTang capital managementMicrosoft wordCapital partnersFinancial instrumentsCapital managementDisclosure guidanceTransparency rules chapterNvestegate alertsK wireUk newsEws alerts

Private equity firms who hold 45% of Kinnate Biopharma Inc. (NASDAQ:KNTE) gained 11%, institutions profited as well

Key Insights The considerable ownership by private equity firms in Kinnate Biopharma indicates that they collectively.

Kinnate biopharmaKinnate biopharma incOrbimed advisorsForesite capital managementTang capital managementPrivate equity firmsInnate biopharma inc

CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) largest shareholders are retail investors with 50% ownership, institutions own 29%

Key Insights Significant control over CytomX Therapeutics by retail investors implies that the general public has more.

Sean mccarthyTang capital managementVanguard group incCytomx therapeutics incCytomx therapeuticsCytomx therapeuticCapital managementVanguard groupCytomx therapeuticsRetail investors

Retail investors in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) are its biggest bettors, and their bets paid off as stock gained 214% last week

Key Insights Corbus Pharmaceuticals Holdings' significant retail investors ownership suggests that the key decisions.

Ikarian capitalVanguard group incTang capital managementCorbus pharmaceuticals holdings incCorbus pharmaceuticals holdingsCapital managementVanguard groupCorbus pharmaceuticalsCorbus pharmaceuticals holdingsNstitutional ownershipInstitutional investorsRetail investors

InflaRx N.V.'s (NASDAQ:IFRX) top owners are individual investors with 55% stake, while 23% is held by institutions

Key Insights Significant control over InflaRx by individual investors implies that the general public has more power to.

Niels riedemannSuvretta capital managementStaidson beijing biopharmaceuticals co ltdPublic company ownershipTang capital managementNdividual investorsOwnership data

vimarsana © 2020. All Rights Reserved.